Select a community
All Communities
Home > Community Treatment Reports > Lamictal Blue (lamotrigine) Treatment Report
What is Lamictal Blue?

Lamictal® Blue is a unit-dose starter kit for patients taking valproic acid. Lamictal is a brand name of the anticonvulsant drug lamotrigine used as an adjuvant medication for seizure control. It is also used for maintenance treatment of bipolar I disorder.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Bipolar Disorder 10 5
Epilepsy 1 1
Leg pain (both) 1 0
Other 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
1 20%
Moderate
3 60%
Mild
1 20%
None
0 0%

Most commonly reported side effects

Dizziness
3 60%
Word fishing
2 40%
Memory problems
1 20%
Nausea
1 20%
absent minded
1 20%
  • Mild
  • Moderate
  • Severe

Dosages

  daily 150 mg daily 200 mg daily 225 mg daily
  10 Number of Patients: 10 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Lamictal Blue (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice
1 100% Doctor's advice: 100%
Course of treatment ended
1 100% Course of treatment ended: 100%

See all 1 patient who’ve stopped taking Lamictal Blue

Duration See details about how long patients take this treatment ▼

Currently Taking Lamictal Blue

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
2
2

Stopped Taking Lamictal Blue

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
3 60%
Usually
2 40%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
3 60%
A little
2 40%
Not at all
0 0%

Cost

Paid out of pocket

$200+
1 20%
$100-199
0 0%
$50-99
0 0%
$25-49
1 20%
< $25
3 60%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.